Biora Therapeutics, Inc. (NASDAQ:BIOR – Get Free Report) was down 10% during trading on Tuesday . The stock traded as low as $0.12 and last traded at $0.12. Approximately 10,686 shares traded hands during mid-day trading, a decline of 83% from the average daily volume of 62,687 shares. The stock had previously closed at $0.13.
Biora Therapeutics Stock Performance
The stock’s fifty day moving average price is $0.14 and its 200-day moving average price is $1.52. The company has a market capitalization of $529,191.00, a P/E ratio of -0.01 and a beta of 1.12.
Biora Therapeutics Company Profile
Biora Therapeutics, Inc, a clinical-stage biotechnology company, engages in developing oral biotherapeutics in the United States. The company offers NaviCap, a targeted oral delivery platform for delivery of therapeutics in the gastrointestinal tract to enhance the treatment of inflammatory bowel diseases; and BioJet, a systemic oral delivery platform designs to replace injection with needle-free, oral delivery of large molecules for management of chronic diseases.
Recommended Stories
- Five stocks we like better than Biora Therapeutics
- Trading Stocks: RSI and Why it’s Useful
- Tariff-Proof Stocks: 3 Big Bargains With Huge Upside Potential
- How to Use Stock Screeners to Find Stocks
- Qualcomm Breaks Down But RSI Signals It’s Severely Oversold
- Bank Stocks – Best Bank Stocks to Invest In
- Tesla’s #1 Bull Cuts Target But Says It’s Still a Buy
Receive News & Ratings for Biora Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Biora Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
